New hope for kidney transplant patients: experimental drug tegoprubart aims to replace tacrolimus
Disease control
ENROLLING_BY_INVITATION
This study is testing a new drug called tegoprubart (AT-1501) to see if it is safe and effective for preventing kidney transplant rejection over several years. About 132 people who have already received a kidney transplant will receive either tegoprubart or the standard drug tacr…
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC